CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182908. A total of 4 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,144,386 | -24.1% | 157,400 | -6.1% | 0.01% | -33.3% |
| Q2 2023 | $9,409,064 | +11.4% | 167,600 | -10.3% | 0.01% | -10.0% |
| Q1 2023 | $8,448,964 | +24.9% | 186,800 | +12.3% | 0.01% | -9.1% |
| Q4 2022 | $6,764,160 | -42.7% | 166,400 | -7.9% | 0.01% | -26.7% |
| Q3 2022 | $11,809,000 | -7.2% | 180,700 | -13.7% | 0.02% | -16.7% |
| Q2 2022 | $12,731,000 | +65.8% | 209,500 | +71.3% | 0.02% | +125.0% |
| Q1 2022 | $7,677,000 | -5.1% | 122,300 | +14.6% | 0.01% | +14.3% |
| Q4 2021 | $8,086,000 | -49.7% | 106,700 | +7.5% | 0.01% | -65.0% |
| Q2 2021 | $16,076,000 | +34.6% | 99,300 | +1.3% | 0.02% | +17.6% |
| Q1 2021 | $11,941,000 | – | 98,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 444,300 | $68,027,000 | 0.12% |
| Marathon Trading Investment Management LLC | 3,400 | $521,000 | 0.03% |
| SIMPLEX TRADING, LLC | 935 | $14,315,000 | 0.02% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |